Teva Pharmaceutical Schedules New York R&D Day to Detail Pipeline Progress and Five-Year Outlook Under Pivot to Growth Strategy
TEL AVIV — Teva Pharmaceutical Industries Ltd. has announced plans to convene an in-person and virtual Research and Development Day in New York City on Wednesday, November 11, 2026, offering…
Stitch Fix Softens 2027 Outlook as Customer Acquisition Costs Spike and Active Client Growth Stalls
Stitch Fix is facing a challenging road ahead, revealing in its latest financial update that it no longer expects its number of active clients to rise in fiscal 2027. Executives…